ecteinascidin 743 has been researched along with nutlin-3a in 1 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (nutlin-3a) | Trials (nutlin-3a) | Recent Studies (post-2010) (nutlin-3a) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 698 | 1 | 504 |
| Protein | Taxonomy | ecteinascidin 743 (IC50) | nutlin-3a (IC50) |
|---|---|---|---|
| Protein Mdm4 | Homo sapiens (human) | 4.6273 | |
| Cellular tumor antigen p53 | Homo sapiens (human) | 1.0388 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.07 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.1832 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alemany, R; Calabuig-Fariñas, S; Felipe-Abrio, I; López-Guerrero, JA; Martín-Broto, J; Martinez-Font, E; Obrador-Hevia, A; Ramos, R; Serra-Sitjar, M | 1 |
1 other study(ies) available for ecteinascidin 743 and nutlin-3a
| Article | Year |
|---|---|
RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response in soft tissue sarcomas.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Dioxoles; DNA Damage; Humans; Imidazoles; Imidazolines; Piperazines; Proto-Oncogene Proteins c-mdm2; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Tumor Suppressor Protein p53 | 2015 |